Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence.
about
Opioid therapy pharmacogenomics for noncancer pain: efficacy, adverse events, and costsReduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups.The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical reviewThe evolution of vertebrate opioid receptorsGenetic susceptibility to heroin addiction: a candidate gene association studyMultiple ADH genes modulate risk for drug dependence in both African- and European-AmericansStatistical significance for hierarchical clustering in genetic association and microarray expression studiesADH4 gene variation is associated with alcohol dependence and drug dependence in European Americans: results from HWD tests and case-control association studiesFunction-altering SNPs in the human multidrug transporter gene ABCB1 identified using a Saccharomyces-based assayRegulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding siteThe diverse applications of cladistic analysis of molecular evolution, with special reference to nested clade analysisMALDI mass spectrometry analysis of single nucleotide polymorphisms by photocleavage and charge-tagging.Model order selection for bio-molecular data clusteringDigital genotyping and haplotyping with polymerase colonies.A simple nonparametric multipoint procedure to test for linkage through mothers or fathers as well as imprinting effects in the presence of linkage.Are molecular haplotypes worth the time and expense? A cost-effective method for applying molecular haplotypes.Haplotype reconstruction for scnp DNA: a consensus vote approach with extensive sequence data from populations of the migratory locust (Locusta migratoria).Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians.Using pathway signatures as means of identifying similarities among microarray experiments.Clone-based systematic haplotyping (CSH): a procedure for physical haplotyping of whole genomes.A simple, bead-based approach for multi-SNP molecular haplotypingThe role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy.Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorderA heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions.Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers.Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.Shifting paradigms in gene-mapping methodology for complex traits.Implications of genome wide association studies for addiction: are our a priori assumptions all wrong?Mu opioid receptor gene: new point mutations in opioid addicts.Genetic variations in human G protein-coupled receptors: implications for drug therapy.A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers.Opioid receptor polymorphisms and opioid abuse.Multiple haplotype-resolved genomes reveal population patterns of gene and protein diplotypes.Haplotype block structure of the genomic region of the mu opioid receptor gene.Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1)A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women.Haplotype analysis in population genetics and association studies.The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk.Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence.Haplotypes and the systematic analysis of genetic variation in genes and genomes.
P2860
Q21284753-9D9D95EE-A147-4F12-B59B-774049C18FA2Q24563892-BBDBC69E-C276-42BA-B19A-3B9B228DBBACQ24616528-69E3D167-0899-45DC-8B2E-EFD2A1197596Q24627645-24493CE4-5F49-4A37-8643-A502850ECDD7Q24634090-4B8F8E76-0BFF-4051-9BF1-2E6465F75A92Q24682204-C7F8DB07-04EF-4B45-95F7-650C883F1669Q24792517-C6807996-7096-4409-A793-2E666FA74F65Q28278084-8E8141AF-ED60-4581-8FE6-6257E8E38F3CQ28469155-F23920BB-95A1-426C-8A32-727972D21500Q28574561-D92DB82F-5085-424D-8174-A53AA6FCD20EQ28748923-8CD1EEC5-059D-4EC2-A884-91E03AC946D5Q30938725-764BBF68-CCF1-49BF-A42A-DF9D5B52A912Q31112220-06CFA7CA-C623-446A-B551-64DE39B7A8FAQ31141262-D496BE7B-8A68-4001-A7AE-C256DC2F1B14Q33232754-42263945-0E37-44BB-8479-544C0FAF4B36Q33255336-1F75C013-CFD7-4FE1-A185-DFACCCFD29B8Q33324164-FCB88634-9F4E-4DC2-A401-D6A87BEEC342Q33330500-3E491C16-3491-41BD-B321-378AF5FDD7B3Q33397732-B2D7DB37-F3C2-4852-A409-3672DA222C3BQ33684357-DB50DD06-F979-49E7-9D0F-4249229833B9Q33754849-D1F11113-C7A3-47EC-A5A3-40D6306A8303Q33883890-3FB28E88-ADCA-4075-B444-F93F12D8C303Q33913645-13554730-FCC9-447D-8D51-B7CF14A8DBC8Q34037595-5FC14CD9-0852-49FC-9F0B-6358D2042A76Q34180425-9676481F-0D04-4C2F-8CBC-5B2E0835F31CQ34330604-04747E33-3063-4282-94F2-26511F657E27Q34355228-093005C0-3513-49C4-AA09-95A33B0C6FD1Q34358797-2C8C66ED-DE9F-47BA-AD66-F726253E621CQ34368193-0A735EE8-A657-497E-93D9-D71D417529A5Q34461998-F4E870B4-67F4-4E7F-BA0F-493E594251CCQ34573827-9D62725F-3157-46D4-8945-E905126966CEQ34612123-B0ED8A50-BF70-4A5C-B8A5-4417FAFE3D69Q34677821-B2BE5D4B-6413-462A-9995-181A626F233CQ34786964-2A433AE4-B210-476D-92D6-B94DC5D74A9FQ34939590-FD0C7871-94B2-4306-93CB-BFBB16FED5A0Q35050878-9385600B-6F18-4E26-81EB-E4CF73D644D4Q35073303-C4698C62-8689-48FE-81D3-57282193194FQ35184664-99763671-F25B-4C78-9F89-E18E19DF87C5Q35189955-6372435A-7A69-4B25-9DDF-87DCFD304397Q35207544-9C84E8F8-3D81-4120-91AF-49CB97F9E4F9
P2860
Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Sequence variability and candi ...... ion with substance dependence.
@en
Sequence variability and candi ...... ion with substance dependence.
@nl
type
label
Sequence variability and candi ...... ion with substance dependence.
@en
Sequence variability and candi ...... ion with substance dependence.
@nl
prefLabel
Sequence variability and candi ...... ion with substance dependence.
@en
Sequence variability and candi ...... ion with substance dependence.
@nl
P2093
P356
P1476
Sequence variability and candi ...... ion with substance dependence.
@en
P2093
Berrettini WH
Flachmeier C
P304
P356
10.1093/HMG/9.19.2895
P577
2000-11-01T00:00:00Z